ClinicalTrials.gg
CompletedNCT07066241Updated Jun 16, 2026

Virtual Reality on Stress, Pain Levels in Patients With Hyperthyroidism Undergoing Biopsy

An interventional study of Virtual Reality Glasses in Virtual Reality and Hyperthyroidism, sponsored by Yuzuncu Yil University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by Yuzuncu Yil University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study aims to investigate the effects of virtual reality on stress, pain levels and vital signs in patients diagnosed with hyperthyroidism who underwent fine needle biopsy.

Read the detailed description

The specific effects of virtual reality on stress, pain levels, and vital signs during fine needle biopsy in patients with hyperthyroidism have not yet been adequately studied. This study aims to investigate the effects of virtual reality on stress, pain levels and vital signs in patients diagnosed with hyperthyroidism who underwent fine needle biopsy.

02

Conditions studied

  • Virtual Reality
  • Hyperthyroidism

Browse trials for

03

In context

Hyperthyroidism

112 studies on the registry are indexed under Hyperthyroidism; 27 are open to participants now.

This study's enrollment of 52 is below the median of 60 across 61 interventional studies indexed under Hyperthyroidism.

Browse Hyperthyroidism studies →

Lead sponsor

Yuzuncu Yil University is the lead sponsor of 78 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Being between 18-80 years old
  2. Agreeing to participate in the study
  3. No obstacle to wearing virtual reality glasses
  4. Patients undergoing for diagnostic purposes
  5. No problems with vision or hearing

Exclusion criteria

Exclusion Criteria:

  1. Those with major psychiatric disorders
  2. Those with any obstacle to communication
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    Experimental group

    During the biopsy, a video with images and sounds of nature will be shown through virtual reality glasses.

    Device: Virtual Reality Glasses

  • No intervention
    Control group

    No application will be made during the biopsy procedure.

Interventions

  • DeviceVirtual Reality Glasses

    The Effect of Virtual Reality on Stress, Pain Levels and Vital Signs in Patients with Hyperthyroidism Undergoing Fine Needle Biopsy

06

What researchers measure

Primary outcomes

  1. Stress; Pain Levels

    questionnaire

    Time frame: pre-intervention, post-intervention (30 mimute)

07

Study locations

1 site
  • Dursun Odabas Medical Center
    Van, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Dec 2025, 5 months.

Of 15 interventional studies with no phase under Hyperthyroidism, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 46. This study's 5 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 25, 2025
First posted
Jul 15, 2025
StartActual
Jul 10, 2025
Primary completionActual
Dec 20, 2025
CompletionActual
Dec 20, 2025
Last update
Jun 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07066241
Lead sponsor
Yuzuncu Yil University
Responsible party
Yavuz Uren (Principal Investigator (Dr.), Yuzuncu Yil University) — Principal investigator
First posted
Jul 15, 2025
Start date
Jul 10, 2025
Primary completion
Dec 20, 2025
Completion
Dec 20, 2025
Last update
Jun 16, 2026

Study contacts

YAVUZ UREN
principal investigator · yavuzuren@hotmail.com

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion